A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects

NCT06921590 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Neurology

Interventions

DRUG: AL001
DRUG: Lithium Carbonate Capsule

Sponsor

Alzamend Neuro, Inc.

Collaborators

[object Object]